No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CRGY240816P10000
- 0.06
- 0.000.00%
15min DelayTrading Jul 11 10:47 ET
0.00High0.00Low
0.00Open0.06Pre Close0 Volume5 Open Interest10.00Strike Price0.00Turnover54.73%IV18.26%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type-0.0723Delta0.0783Gamma202.67Leverage Ratio-0.0046Theta-0.0006Rho-14.65Eff Leverage0.0044Vega
Intraday
- 5D
- Daily
News
Truist Securities Maintains Buy on Crescent Energy, Lowers Price Target to $19
Truist Securities analyst Neal Dingmann maintains Crescent Energy (NYSE:CRGY) with a Buy and lowers the price target from $20 to $19.
Truist Financial Maintains Crescent Energy(CRGY.US) With Buy Rating, Cuts Target Price to $19
Truist Financial analyst Neal Dingmann maintains $Crescent Energy(CRGY.US)$ with a buy rating, and adjusts the target price from $20 to $19.According to TipRanks data, the analyst has a success rate
Express News | Crescent Energy Co : Truist Securities Cuts Target Price to $19 From $20
Sector Update: Energy Stocks Rise Pre-Bell Friday
Energy stocks were higher premarket Friday with the Energy Select Sector SPDR Fund (XLE) recently up 0.2%.The United States Oil Fund (USO) was 0.1% lower and the United States Natural Gas Fund (UNG)
Crescent Energy Says Proxy Advisory Firms Recommend Shareholders Approve SilverBow Deal
Crescent Energy (CRGY) said late Thursday that proxy advisory firms Institutional Shareholder Services and Glass Lewis have each recommended that shareholders approve the company's pending merger
Express News | Crescent Energy - Institutional Shareholder Services, Glass Lewis Recommend Crescent Shareholders Vote "for" Proposed Merger With SilverBow Resources
Comments
Crescent Energy's low P/S ratio may reflect market doubts about future revenue growth, despite industry-aligned expectations. Shareholders may foresee revenue instability, typically a share price support.
Investors Continue Waiting On Sidelines For Crescent Energy Company (NYSE:CRGY)
$Berkshire Hathaway 13F(LIST2999.US$ $Berkshire Hathaway-A(BRK.A.US$ $Berkshire Hathaway-B(BRK.B.US$ $Apple(AAPL.US$ $Coca-Cola(KO.US$ $Bank of America(BAC.US$ $Occidental Petroleum(OXY.US$ $Expedia(EXPE.US$ $CVS Health(CVS.US$ $Signet Jewelers(SIG.US$ $Warner Bros Discovery(WBD.US$ $Liberty Latin America-C(LILAK.US$ $Crescent Energy(CRGY.US$ $Nexstar Media Group(NXST.US$ $Charter Communications(CHTR.US$ $Precision Drilling(PDS.US$ $The Cigna Group(CI.US$ $Vital Energy(VTLE.US$
3
2
Gapping up
In reaction to earnings/guidance:
• $Coupa Software(COUP.US$ +12% (also authorizes new $100mln share repurchase program), $REV Group(REVG.US$ -5%, $G-III Apparel Group(GIII.US$ + 2.1%, $Gitlab(GTLB.US$ +1.2%
Other news:
• $Tupperware Brands(TUP.US$ +6.7% (recovers a bit after falling -33% during regular session)
• $Avaya Holdings(AVYA.US$ +6.6% (authorizes workforce reduction plan)
• $Bassett Furniture Industries(BSET.US$ +5% (acqu...
In reaction to earnings/guidance:
• $Coupa Software(COUP.US$ +12% (also authorizes new $100mln share repurchase program), $REV Group(REVG.US$ -5%, $G-III Apparel Group(GIII.US$ + 2.1%, $Gitlab(GTLB.US$ +1.2%
Other news:
• $Tupperware Brands(TUP.US$ +6.7% (recovers a bit after falling -33% during regular session)
• $Avaya Holdings(AVYA.US$ +6.6% (authorizes workforce reduction plan)
• $Bassett Furniture Industries(BSET.US$ +5% (acqu...
7
3
Gainers:
• $Day One Biopharmaceuticals(DAWN.US$ +67.7% (Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma)
• $Gracell Biotechnologies(GRCL.US$ +12.1% (Presents Updated Clinical Data for BCMA/CD19 Dual-targeting FasTCAR GC012F in RRMM at EHA2022 Congress, Highlighting 100% MRD Negativity Rate in All Treated Patients)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US$ +6...
• $Day One Biopharmaceuticals(DAWN.US$ +67.7% (Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma)
• $Gracell Biotechnologies(GRCL.US$ +12.1% (Presents Updated Clinical Data for BCMA/CD19 Dual-targeting FasTCAR GC012F in RRMM at EHA2022 Congress, Highlighting 100% MRD Negativity Rate in All Treated Patients)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US$ +6...
16
5
Gainers:
• $SailPoint Technologies(SAIL.US$ +30% (confirms agreement to be acquired by Thoma Bravo for $6.9 bln; stockholders to receive $65.25 per share in cash)
• $Veru Inc(VERU.US$ +28.9% (Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy)
• $Affimed NV(AFMD.US$ +12.9% (Presents Upda...
• $SailPoint Technologies(SAIL.US$ +30% (confirms agreement to be acquired by Thoma Bravo for $6.9 bln; stockholders to receive $65.25 per share in cash)
• $Veru Inc(VERU.US$ +28.9% (Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy)
• $Affimed NV(AFMD.US$ +12.9% (Presents Upda...
21
4
Read more